Perrigo Expands OTC Growth Strategy With Rx-To-OTC Switch Licensing For Nasonex®

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. SPCX
4. ACN
5. IBM
6. NVDA
7. PRIM
8. META
9. SPY
10. TSLA

Go back to Perrigo Expands OTC Growth Strategy With Rx-To-OTC Switch Licensing For Nasonex®
Perrigo (NYSE: PRGO) Delayed: 9.43 -0.17 (1.77%)
Previous Close $9.60    52 Week High $156.03 
Open $9.66    52 Week Low $79.72 
Day High $9.76    P/E N/A 
Day Low $9.40    EPS $0.00 
Volume 842,524       

Perrigo (NYSE: PRGO) Delayed: 9.43 -0.17 (1.77%)
Previous Close $9.60    52 Week High $156.03 
Open $9.66    52 Week Low $79.72 
Day High $9.76    P/E N/A 
Day Low $9.40    EPS $0.00 
Volume 842,524